NCT04521790View on ClinicalTrials.gov

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2035

Conditions

MyocarditisVentricular ArrythmiaInflammatory CardiomyopathyGenetic PredispositionAutoimmunityArrhythmiaCardiomyopathiesImmunosuppressionCatheter Ablation

Interventions

OTHER

support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation

Treatment will be patient-tailored, integrating international guidelines recommendation and the experience of the center where enrollment takes place.

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors

lead

Scientific Institute San Raffaele

OTHER